Transient Inactivation of Rb and ARF Yields Regenerative Cells from Postmitotic Mammalian Muscle  by Pajcini, Kostandin V. et al.
Cell Stem Cell
ArticleTransient Inactivation of Rb and ARF
Yields Regenerative Cells
from Postmitotic Mammalian Muscle
Kostandin V. Pajcini,1 Stephane Y. Corbel,1 Julien Sage,2 Jason H. Pomerantz,1,3,* and Helen M. Blau1,*
1Baxter Laboratory for Stem Cell Biology, Department of Microbiology & Immunology, Institute for Stem Cell Biology
and Regenerative Medicine
2Departments of Pediatrics and Genetics
Stanford University School of Medicine, Stanford, CA 94305, USA
3Present address: Department of Surgery, Division of Plastic andReconstructive Surgery, Program in Craniofacial andMesenchymal Biology,
Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, CA 94143, USA
*Correspondence: jason.pomerantz@ucsfmedctr.org (J.H.P.), hblau@stanford.edu (H.M.B.)
DOI 10.1016/j.stem.2010.05.022SUMMARY
An outstanding biological question is why tissue
regeneration in mammals is limited, whereas urodele
amphibians and teleost fish regenerate major struc-
tures, largely by cell cycle reentry. Upon inactivation
of Rb, proliferation of postmitotic urodele skeletal
muscle is induced, whereas in mammalian muscle
this mechanism does not exist. We postulated that
a tumor suppressor present in mammals but absent
in regenerative vertebrates, the Ink4a product ARF
(alternative reading frame), is a regeneration sup-
pressor. Concomitant inactivation of Arf and Rb led
to mammalian muscle cell cycle reentry, loss of dif-
ferentiation properties, and upregulation of cytoki-
netic machinery. Single postmitotic myocytes were
isolated by laser micro-dissection-catapulting, and
transient suppression ofArf andRb yieldedmyoblast
colonies that retained the ability to differentiate and
fuse into myofibers upon transplantation in vivo.
These results show that differentiation of mammalian
cells is reversed by inactivation of Arf and Rb and
support the hypothesis that Arf evolved at the
expense of regeneration.
INTRODUCTION
Tissue regeneration in humans is extremely limited, which
constitutes a major challenge to the repair of damaged organ
and tissue function. Humans and other mammals do not
regenerate large portions of lost muscles or other mesenchymal
structures after traumatic injury or surgical excision. By contrast,
some vertebrates such as the urodele amphibians and the
teleost fish have a remarkable capacity to regenerate entire
limbs, the lens of the eye, and portions of the heart (Poss et al.,
2002; Brockes and Kumar, 2008; Tanaka and Weidinger,
2008). Although classically defined resident stem cells clearly
play a role in tissue regeneration, their relatively low frequency
in a given tissue may be insufficient to account for the massive198 Cell Stem Cell 7, 198–213, August 6, 2010 ª2010 Elsevier Inc.regeneration observed in some lower vertebrates. In zebrafish,
heart regeneration results from dedifferentiation and subsequent
proliferation of cardiomyocytes (Poss et al., 2002). Substantial
evidence from studies of newts and axolotls supports a similar
regenerative mechanism, in which postmitotic limb tissues
including muscles lose their differentiation markers, re-enter
the cell cycle, proliferate, and then recapitulate differentiation
in the blastema (Hay and Fischman, 1961; Lentz, 1969; Kintner
and Brockes, 1984; Lo et al., 1993; Gardiner and Bryant, 1996;
Echeverri et al., 2001). Recent observations strongly suggest
that dedifferentiated cells of the limb remain lineage committed
during this process (Kragl et al., 2009). In marked contrast, there
is no evidence that dedifferentiation occurs as a natural part of
tissue regeneration in mammals. This raises the possibility that
a mechanism of regeneration involving reversal of differentiation
of mesenchymal tissues, such as muscle, may have been lost
or suppressed during evolution of higher vertebrates that, if
elucidated, could significantly impact regenerative medicine.
Muscle differentiation in mammals occurs by a stepwise
progression. This process entails morphological and functional
changes driven by the expression of a series of muscle regula-
tory factors (MRFs), which induce expression of differentiation-
specific genes such as creatine kinase and myosin heavy chain
(MHC) (Molkentin and Olson, 1996). In particular, myogenin
heralds a transition from proliferative myoblast to committed
postmitotic muscle cell (Walsh and Perlman, 1997; Charge´ and
Rudnicki, 2004). Of critical importance to this transition is the
expression of the retinoblastoma protein (pRb) (Gu et al., 1993;
Lassar and Mu¨nsterberg, 1994; Novitch et al., 1996; Huh et al.,
2004). The role of pRb in differentiation is multifaceted, including
not only the orchestration of mitotic arrest and prevention of cell
cycle reentry, but also inhibition of apoptosis and enforcement of
stable tissue-specific gene expression (Burkhart and Sage,
2008). Because the differentiated state requires continuous
active control (Blau et al., 1985; Blau andBaltimore, 1991; Yama-
naka and Blau, 2010), ongoing expression of pRb or possibly
redundant pocket proteins would be predicted to be necessary
for the maintenance of the specialized muscle cell phenotype.
Attempts to reverse differentiation and postmitotic arrest in
mammalian skeletal muscle cells by either acute suppression
or permanent elimination of Rb have produced conflicting
results. In newt muscle cells, cell cycle reentry and DNA
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(Tanaka et al., 1997). Similarly, the inactivation of pRb by viral
oncoproteins in immortalized mammalian myoblast cell lines,
such as C2C12, readily results in BrdU incorporation and S
phase reentry in nuclei of differentiated myotubes (Gu et al.,
1993; Crescenzi et al., 1995), and is in agreement with more
recent studies that use siRNA to suppress Rb (Blais et al.,
2007). In marked contrast, in similar experiments with primary
muscle cells isolated directly from mammalian muscle tissues,
Rb reduction or elimination by Cre-mediated excision failed to
result in significant S phase reentry (Sacco et al., 2003; Camarda
et al., 2004; Huh et al., 2004). These data suggest that Rb loss in
primary differentiated skeletal muscle cells is not sufficient to
induce reversal of the postmitotic state in mammals, in stark
contrast to the situation in urodeles.
We reasoned that components of the mammalian cell cycle
machinery known to be absent in lower organisms could have
evolved at the expense of regeneration. A prime candidate is
the Ink4a locus, which encodes the structurally and functionally
unrelated products p16ink4a and ARF (alternative reading
frame). Both of these proteins are potent tumor suppressors
that are frequently inactivated in human and mouse cancers.
p16ink4a specifically inhibits cdk4 and functions upstream of
Rb, whereas ARF bindsMDM2,which results in p53 stabilization,
in addition to having p53-independent functions (Sherr et al.,
2005). Notably, ARF responds to oncogenic stimuli, including
the inactivation of Rb, by inducing p53-dependent growth arrest
or apoptosis (Sharpless and DePinho, 1999; Sherr et al., 2005).
Although the Rb and p53 pathways are evolutionarily ancient,
their regulation by the Ink4a locus is a relatively new phenom-
enon. Homologs of p16ink4a exist in fish (Kazianis et al., 1999;
Gilley and Fried, 2001). But the earliest identified ARF ancestor
is in chickens, with no candidates in databases of lower organ-
isms (Gilley and Fried, 2001; Kim et al., 2003; Brookes et al.,
2004). Thus, the absence of ARF relatives could underlie certain
fundamental differences in growth control in lower vertebrates.
Here we test the hypothesis that reversal of differentiation of
mammalian skeletal muscle cells can be induced by inactivation
of Rb in conjunction with ARF. Specifically, we postulated that
upon loss of Rb, growth arrest and differentiation are maintained
by inductionof expressionof the tumor suppressorARF.Our data
show that transient suppression of both Rb and ARF results in
the ability of skeletal muscle cells to lose their differentiated
properties, cycle, and then redifferentiate in amanner thatmimics
urodele cells.Weusedbothgenetic andbiochemical approaches
in primary cells and monitored single cell behavior by time-lapse
microscopy, which enabled a rigorous analysis of the intrinsic
control ofmuscle cell proliferation andmodulation of the differen-
tiated phenotype. The use of photoactivated laser microdissec-
tion (PALM) and laser pressure catapulting (LPC) to isolate single,
morphologically intact, adherent, primary differentiated cells
(myocytes) allowed the unambiguous identification of clones
from individual cells. Based on our findings, we propose amolec-
ular mechanism whereby evolution of ARF in part explains
differences between urodele and mammalian skeletal muscle
regeneration. The results suggest a means of replicating in
mammals the robust regenerative response typical of urodeles,
demonstrating that the transient induction of dedifferentiation
could serve as an adjunct to classical tissue-specific stem cells.RESULTS
Suppression of Rb by siRNA Induces S Phase Reentry
in C2C12 Myotubes
The myoblast cell line C2C12 is a model system for studying
muscle differentiation in vitro. In differentiation medium (DM),
confluent C2C12 myoblasts exit the cell cycle and fuse with
one another to form multinucleated muscle cells (myotubes),
which express muscle proteins and are contractile. We devel-
oped a protocol to transiently express siRNAs in 66.8% of
myotubes via the siImporter reagent (Figures S1A and S1B avail-
able online). To determine the duration and efficiency of siRNA
treatment, C2C12 myotubes were treated with siRNAs against
Rb (Rbsi) (Figures 1A and 1B). Semiquantitative RT-PCR and
western analysis confirmed transient suppression of Rb tran-
script and protein levels (Figures 1B–1D). Treatment with Rbsi re-
sulted in a decrease of pRb protein levels (Figure 1C) to approx-
imately 50% ± 22% of the levels in control myotubes (Figure 1D).
These data show that with siRNAs, pRb can be substantially
reduced for a period of 48 hr.
To determine whether S phase reentry in C2C12 myotubes
occurred after transient suppression of Rb, we labeled Mocksi-
and Rbsi-treated myotubes with BrdU, as indicated in the
scheme in Figure 1A. BrdU-labeled myonuclei were observed
inside MHC+ myotubes only after Rbsi treatment. S phase
reentry was dependent on the dose of Rbsi used and doubled
from 25.7% to 52.8% as the siRNA concentration was increased
from 100 to 200 nM (Figure 1E). The 200 nm concentration was
used in subsequent experiments. The percentage of myotubes
that contained any BrdU-positive nuclei was analyzed in a sepa-
rate set of experiments and found to be 25% (Figure S1H), which
is explicable because myotubes with Brdu-positive nuclei often
had large clusters of nuclei that underwent DNA synthesis, prob-
ably reflecting the successful transfection of a fraction of the
cells in the culture (Figure S1A). Figure 1F shows representative
images of BrdU incorporation together with MHC immunostain-
ing to confirm differentiation. We found a marked change in
myotube morphology 72 hr after transfection of Rbsi (Figure 1D,
bottom) from a compact elongated structure with characteristic
linear nuclear alignment to an amorphous structure, with nuclei
aggregated in clusters, many of whichwere BrdU positive. These
data confirm that transient suppression of Rb is sufficient to
induce S phase reentry in differentiated C2C12 myotube nuclei
and show that the extent of this effect depends on the concen-
tration of Rbsi used.
Both Rb and p19ARF Must Be Suppressed
for S Phase Reentry in Primary Myotubes
Themajority of the data that suggest that suppressingRb is suffi-
cient for cell cycle reentry in mature mammalian myotubes
comes from experiments with the C2C12 cell line (Gu et al.,
1993; Velloso et al., 2001; Blais et al., 2007). Although useful
for studying muscle cell differentiation and fusion (Pajcini et al.,
2008), we reasoned that C2C12 cells, like other cell lines, may
have acquired mutations essential to their immortalization.
Therefore, we considered it critical to use primary cells to assess
the role of pRb in maintaining the postmitotic state. We har-
vested primary myoblasts as previously described (Rando and
Blau, 1994) from Rosa26-CreERT2 Rblox/lox mice (Viatour et al.,Cell Stem Cell 7, 198–213, August 6, 2010 ª2010 Elsevier Inc. 199
Figure 1. Suppression of Rb Is Sufficient for Cell Cycle
Reentry in C2C12 Myotubes
(A) Schematic representation of the treatment of C2C12
myotubes.
(B) sqRT-PCR of Rb expression time course in hours after
treatment with mocksi or Rbsi. GAPDH expression shown as
RNA loading control.
(C) Western blot of protein expression levels of Rb (100 kDa) in
C2C12 myoblasts (GM), myotubes (DM4), and myotubes at DM3
and DM4, 24 hr and 48 hr, respectively, after treatment with
Rb-siRNA. GAPDH (35 kDa) as a loading control.
(D) Histogram representing the levels of Rb in GM, in DM4, and in
DM4 treated with Rb-siRNA for 48 hr. Samples are normalized to
Rb levels of DM4 myotubes.
(E) Histogram represents BrdU incorporation in myonuclei of
myotubes in day 4 of differentiation (DM4), at least 36 hr after
Rbsi treatment. A minimum of 500 nuclei were counted from
random fields for each trial.
(F) Immunofluorescence images from mock-treated DM4 C2C12
myotubes and 200 nM Rbsi-treated myotubes in DM4 and DM5.
Myotubes were labeled with primary antibody for MHC (red) and
BrdU (green), as well as with Hoechst 33258 dye (blue). Scale
bars represents 150 mm. Growth medium (GM); myotubes
cultured in differentiation medium for 4 or 5 days (DM4 or DM5,
respectively).
Error bars indicate the mean ± SE of at least three independent
experiments, p value was determined with a t test (*p < 0.05,
**p < 0.01).
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dase reporter allele (Soriano, 1999). In these mice, Cre expres-
sion and Rb excision is dependent on tamoxifen (TAM) induction
(Figures S1C and S1D). In primary myotube cultures, a single
24 hr treatment with 1 mM TAM was sufficient to reduce Rb
expression (Figure S1E). Both transcript and protein levels
dropped substantially by 96 hr after TAM treatment (Figure 2C;
Figure S1F).
We analyzed S phase reentry in primary myotubes after loss of
Rb expression according to the scheme in Figure 2A. In contrast
to C2C12 myotubes, in primary myotubes regardless of whether
Rb was knocked down by Rbsi (Figure 2B) or excised by Cre
expression (Figure 2D, top), in more than 1500 nuclei scored
from random fields of MHC+ myotubes, BrdU labeling of myonu-
clei was relatively rare (Figure 2G). In the representative images200 Cell Stem Cell 7, 198–213, August 6, 2010 ª2010 Elsevier Inc.in Figures 2B and 2D, BrdU+ nuclei are detectable, but
these are generally not within MHC+ myotubes. Thus,
loss of Rb in primary myotubes is not sufficient to
induce cell cycle reentry.
We observed that acute suppression of Rb in
primary myotubes led to upregulation of p19ARF
mRNA (Figure S1F) and protein (Figure 2C, third
lane). These results are in agreement with previous
reports showing that disruption of Rb function by
mutation or by hyperphosphorylation in response to
mitogenic signals leads to the activation of ARF
(DeGregori et al., 1997; Sage et al., 2003). ARF, in
turn, serves to block inappropriate cycling. Induction
of ARF was accompanied by a mild increase in base-
line levels of apoptosis, but the majority of myotubes
remained robust and viable. Apoptosis was rarelyobserved in siRNA-treated cells in which p16/p19 was reduced
(Figure S1I).
In contrast to primary cells, p19ARF was not detected in
C2C12 myotubes in response to Rb suppression (Figure 2E).
We determined by genomic PCR analysis that the lack of
p19ARF expression in C2C12 cells was due to a deletion in the
Ink4a locus (Figure 2F), a characteristic of murine cell lines
immortalized by continuous passage in culture (Sherr and
DePinho, 2000). These observations suggested that the dispa-
rate cell cycle reentry responses of primary and immortalized
muscle cells to loss of Rb might be related to the status of
ARF. To test whether the suppression of the Ink4a gene products
in Rb-deficient primary myotubes would permit reentry, we de-
signed siRNAs that target the shared exon 2 region of Ink4a
mRNA (p16/19si), the ARF-specific exon 1b (p19ARFsi), and
Figure 2. Suppression of Rb and p16/19
Is Necessary for Cell Cycle Reentry in
Primary Myotubes
(A) Schematic representation of the treatment of
primary myotubes with either tamoxifen (TAM)
and/or siRNA.
(B) Immunofluorescence images from mock
si-Glo-treated primarymyotubes and Rbsi-treated
myotubes. Myotubes were labeled with primary
antibody for MHC (red) and BrdU (green), as well
as with Hoechst 33258 dye (blue). Scale bar
represents 50 mm.
(C)Western blot of primarymyotube protein levels;
Rb (100 kDa) and p19ARF (20 kDa) in GM and
DM5, after TAM treatment or TAM and p16/19si
treatment. GAPDH (35 kDa) as loading control.
(D) Immunofluorescence images indicating BrdU
incorporation in TAM- and mock si-Glo-treated
primary myotubes compared to TAM- and p16/
19si-RNA-treated primary myotubes.
(E) sqRT-PCR showing Rb and Ink4a (p16/19)
expression in primary myotubes as well as in two
different C2C12 myotube populations treated
with Mocksi or Rbsi.
(F) sq-PCR amplification with primers for the
shared exon 2-3 region of the ink4a locus, from
genomic DNA prepared from primary myoblasts
and C2C12 myoblasts.
(G) Histogram represents BrdU incorporation in
primary myotube nuclei at DM5, after suppression
of Rb with either siRNA or TAM.
(H) Histogram represents BrdU incorporation in
primary myotube nuclei after treatment with TAM
and siRNAs against ink4a gene products. A
minimum of 500 nuclei were counted from random
fields for each trial in (G) and (H).
Error bars indicate the mean ± SE of at least three
independent experiments. *p < 0.01.
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with TAM or Rbsi, then 24 hr later transfected either with p16si,
p16/19si, p19ARFsi alone, or both p16/19si and p19ARFsi
together (see scheme in Figure 2A). Gene knockdown in
myotubes was verified by western analysis (Figure 2C) and by
RT-PCR (Figure S1G). When labeled with BrdU after TAM and
p16/19si treatment, differentiated myonuclei incorporated
BrdU in MHC-positive myotubes (Figure 2D). Quantification of
the BrdU labeling indicated that 45.7% ± 7.2% of myonuclei
enter S phase in TAM- and p16/19si-treatedmyotubes, amarked
increase over baseline values observed in myotubes treated
only with TAM or p16/19si (Figures 2G and 2H). Different
combinations of siRNAs that exclusively induced knockdown
of p19ARF or that targeted both Ink4a gene products in
TAM-treated cells yielded similar results (Figure 2H). Notably
knockdown of p16 alone after TAM treatment did not increase
BrdU incorporation above background levels (data not shown),
suggesting that ARF was primarily responsible for the observed
Ink4a effects. Therefore, for subsequent experiments we used
the p16/19si (exon 2) because it produced the strongestsuppression of p19ARF. Thus, robust S phase reentry in differen-
tiated primarymammalianmyotubes occurs only after combined
suppression of both Rb and p19ARF.
Upregulation of Mitotic and Cytokinetic Components
in Rb- and p16/19-Deficient Myonuclei
To determine whether S phase reentry in primary myonuclei
marked the initiation of the mitotic process, we analyzed control
or TAM- and p16/19si-treated nuclei for the induction of expres-
sion of a panel of mitotic and cytokinetic proteins. AuroraB and
survivin are components of the chromosome passenger com-
plex (CPC), which controls spindle structure, kinetochore attach-
ment, and chromosome segregation (Ruchaud et al., 2007).
Anillin is important in the organization of the cleavage furrow
during cytokinesis (Hickson and O’Farrell, 2008). In addition,
we characterized expression of cyclins D1 and E as well as
Emi1/FBXO5, which regulates progression through early mitosis
by preventing premature activation of APC (Reimann et al.,
2001). We analyzed mitotic progression by investigating the
localization of Eg5, a motor protein in the kinesin-like familyCell Stem Cell 7, 198–213, August 6, 2010 ª2010 Elsevier Inc. 201
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Mitchison, 1995).
Anillin and each of the CPC components described above are
expressed in primary proliferating myoblasts, but their mRNA
and protein levels drop precipitously once myotubes form
(Figures S2A and S2B). When Rb was excised in differentiated
primary multinucleated myotubes after TAM treatment, anillin,
AuroraB, and survivin mRNA levels all rose, despite high levels
of p19ARF expression (Figure S2A). However, protein levels of
AuroraB and survivin were comparable to those of growing
myoblasts only after concomitant suppression of Rb and
p19ARF (Figure S2B). To verify that upregulation of CPC compo-
nents occurred specifically in myonuclei that had entered S
phase, primary myoblasts were labeled with BrdU for 12 hr
then stained for BrdU and survivin. Dividing primary myoblasts
were positive for both BrdU and survivin, with the latter marking
the cleavage furrow (data not shown). Differentiated, control-
treated myotubes did not have myonuclei that expressed
survivin, but those treated with TAM and p16/19si exhibited clus-
tered BrdU+ myonuclei, and in these same myonuclei survivin
expression was upregulated (Figure S2C, bottom). Although
survivin was not localized in organized cleavage furrows, quan-
tification of the immunostaining results indicated that nearly
80% of the myonuclei that had re-entered S phase also upregu-
lated survivin (Figure S2D).
Analysis of the expression of cyclins D and E1 showed that
these gene products are expressed in proliferating myoblasts
and downregulated in differentiated myotubes. Upon treatment
with either TAM or with TAM and p16/19si together, there was
a rise in the expression of these cyclins as well as Emi1/
FBXO5 (Figure S2E). These data indicate that mature myonu-
clei in myotubes progress through S phase. In order to
determine the extent of mitotic progression, we analyzed Eg5
localization in myotubes treated with TAM and p16/19si. Our
results indicate that despite upregulation of Eg5, bipolar spin-
dles did not form in Rb- and p16/19-deficient myotubes,
although monopolar clustering of Eg5 was frequently observed
(Figure S2F). Full karyokinesis or cytokinesis was not observed
in myotubes.
Taken together, our data suggest that primary multinucleated
myotubes deficient in both pRb and ARF synthesize DNA and
components of the mitotic machinery, but fail to assemble
these proteins in amanner required for nuclear division.Whereas
the incorporation of BrdU and expression of Ki67 mark the
occurrence of S phase, Aurora B is maximally expressed in
G2-M. Moreover, survivin is synthesized in G2-M only in accor-
dance with the cell cycle-dependent CDE/CHR boxes in its
promoter and posttranslational stabilization that occurs at this
cell cycle phase (Kobayashi et al., 1999; Li and Altieri, 1999).
However, the diffuse pattern of survivin immunostaining (Fig-
ure S2C) indicates that the nuclei in dedifferentiating mytotubes
did not enter prophase, during which survivin staining becomes
punctate (Caldas et al., 2005). Furthermore, Eg5, although
upregulated at the protein level, does not form the typical
pericentrosomal clustering signifying the onset of prophase
(Sawin and Mitchison, 1995). Thus, our data indicate that sup-
pression of pRb and ARF in intact myotubes results in progres-
sion through S phase to G2, but the nuclei cannot complete
M phase and are arrested at the onset of mitosis.202 Cell Stem Cell 7, 198–213, August 6, 2010 ª2010 Elsevier Inc.Dedifferentiation Accompanies S Phase Reentry
in Primary Muscle Cells
Postmitotic differentiated muscle cells express phenotypic
markers such as myosin heavy chain (MHC) and a characteristic
elongatedmorphology that results, in part, from the arrangement
of the microtubule network. During differentiation, the microtu-
bule cytoskeleton shifts from the radial, centrosomal arrange-
ment typical of myoblasts andmost mononucleated mitotic cells
to a noncentrosomal array that extends along the longitudinal
axis of the multinucleated myotube (Bartolini and Gundersen,
2006). We investigated the role of the Rb and Ink4a gene
products in sustaining expression of the differentiated pheno-
type by analyzing morphology and expression of markers of
differentiation. Immunostaining demonstrated that MHC is not
expressed in proliferating myoblasts or during early differentia-
tion, but is readily detectable in all nascent myotubes by day 4
in differentiation media (Figure 3A, top). Treatment with tamox-
ifen after differentiation did not significantly alter myotube
morphology and did not result in a detectable change in MHC
levels by immunostaining (Figure 3A, bottom right). However,
combined deletion of Rb and suppression of ink4a caused
a marked decrease in MHC expression in cultures that had
previously been differentiated (Figure 3A, bottom). Although
intact, multinucleated and viable myotubes were present at
days 6 and 7 of differentiation, cells that were rendered deficient
in Rb and ink4a products lost structural integrity and began to
collapse by day 6. By day 7, primary myotube morphology and
MHC levels had severely deteriorated when compared to
myotubes treated only with TAM and mock siRNAs (Figure 3A,
bottom).
The combined suppression of Rb and p16/19 resulted in
a decrease in levels of differentiation-specific muscle proteins
in addition to MHC. Rb loss alone in primary myotubes treated
with TAM led to a moderate reduction in some myogenic protein
levels, such as MHC and myogenin (Figures 3B, 3C, and 3F) and
a moderate increase in the mitotic proteins AuroraB and survivin
(Figure 3B). However, suppression of both Rb and p19ARF was
more profound and accompanied by substantially reduced
levels of myogenin and M-CK in addition to MHC (Figure 3F;
Figure S3D, upper band). In agreement with findings in primary
myotubes in which both Rb and p19/ARF proteins were absent,
western blot analyses of C2C12 myotubes, which already lack
p19ARF, exhibited decreased MHC levels when treated only
with Rbsi (Figure S3A). Expression levels ofMRF4 also declined.
Semiquantitative RT-PCR analyses revealed a decrease in RNA
levels that paralleled these protein data (Figure S3C).
Immunofluorescence (IF) analysis of myotubes revealed
several morphological differences in TAM and p16/19si
myotubes when compared to Mocksi myotubes. In addition to
incorporating BrdU by day 6 of differentiation, treated myotubes
were significantly less compact than controls, never exhibited
striations, and appeared to have large gaps in their MHCnetwork
(Figure 3D). Whereas mock-treated primary myotubes retained
their elongated morphology and nuclear organization, BrdU+
myotubes collapsed into amorphous multinucleated syncytial
structures, highlighted by the clustering of myonuclei. Although
not all of the myonuclei entered S phase, loss of structural
integrity of the myotube is probably due to the lack of mainte-
nance of myotube nuclear protein domains. Morphological
Figure 3. Dedifferentiation of Mature Myo-
tubes
(A) Immunofluorescence images of primary
myoblasts and myotubes cultured for indicated
times in DM and treated with TAM and either
nonspecific siRNA (Mocksi) or p16/19si at the
indicated time points. Myotubes were labeled
with primary antibodies for MHC (red) and
Hoechst 33258 (blue). Bottom panels: phase
images of the same image fields. Scale bars
represent 150 mm.
(B) Western blot analysis of primary myoblasts
in GM and DM5 showing expression of MHC
(220 kDa), AuroraB (38 kDa), and Survivin
(20 kDa) as well as expression of these same
proteins in myotubes after treatment for at least
48 hr with siRNA against p16/19, with TAM or
both TAM and p16/19si.
(C) MHC protein levels normalized to differentiated
myotube cultures. Primary myotubes were treated
with TAM or TAM and p16/19si. Growth medium
(GM), differentiation medium (DM). Error bars
indicate the mean ± SE of at least three indepen-
dent experiments.
(D) Representative immunofluorescence images
of DM6 primary myotubes treated with EtOH and
nonspecific siRNA or TAM and p16/19si for at
least 48 hr. Myotubes were labeled with primary
antibodies for MHC (red), BrdU (green), and
Hoechst 33258 (blue).
(E) Representative immunofluorescence images of
primary DM6 myotubes after Mocksi or TAM and
p16/19si treatment. Myotubes were labeled with
primary antibodies for a-tubulin (green) and
Hoechst 33258 (blue).
(F and G) Western blot analysis of Myogenin (36
kDa) (F) and a-tubulin (50 kDa) (G) in primary
myoblasts and myotubes treated as indicated
with siRNA and/or TAM. In each of the blots,
GAPDH (35 kDa) is the loading control. Growth
medium (GM); myotubes were cultured in differen-
tiation medium for 3 or 6 days (DM3 or DM6,
respectively).
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BrdU+ staining in C2C12 myotubes; however, only loss of pRb
was required (Figure S3B).
To further investigate the deterioration in myotube mor-
phology, we analyzed the expression and arrangement of
a-tubulin in mature myotubes. In mock-treated myotubes,
a-tubulin is expressed at high levels and microtubules are
arranged longitudinally, whereas in TAM- and p16/19si-treated
myotubes, a-tubulin levels are lower by IF (Figure 3E) and
western analysis (Figure 3G; Figures S3E and S3F). To dynami-
cally visualize structural deterioration, myotubes were imagedCell Stem Cell 7, 198–21by time-lapsemicroscopy after treatment
with TAM and Mocksi (Movie S1) or TAM
and p16/19si (Movie S2). A time-lapse
comparison shows that complete mor-
phological collapse of myotube structure
takes place only after loss of both the Rb
as well as Ink4a gene products. Despite
extensive structural differences, the Rb-and ink4a-deficient primarymyotubes do not die or detach faster
than Mocksi-treated myotubes, and they retain their motility and
membrane activity, such as filopodia and lamellapodia.
Terminally Differentiated Myocytes Are Capable
of Proliferation after Suppression of Rb and p16/19
The extent of muscle differentiation can be characterized based
on the sequential expression of muscle regulatory transcription
factors (MRFs). MyoD and Myf5 are early and characteristic of
cycling myoblasts, whereas late transcription factors include
myogenin and MRF4, which are expressed in terminally3, August 6, 2010 ª2010 Elsevier Inc. 203
Figure 4. Myogenin-Expressing Myocytes
Enter S Phase Only after Loss of Rb and
ink4a Gene Products
(A) Immunofluorescence images of myoblasts
(GM) and myocytes (DM3) infected with pLE-
myog3R-GFP. Cells were labeled with primary
antibodies for GFP (green), myogenin (red), and
Hoechst 33258 (blue). Scale bar represents 50 mm.
(B) (i) Histogram represents percentage of
GFP-positive (green bars) and myogenin-positive
(red bars) cells in growth medium (GM) or differen-
tiation medium (DM3). A minimum of 1000 nuclei
were counted from random fields for each trial.
Error bars indicate the mean ± SE of at least
three independent experiments (*p < 0.005). (ii)
Histogram represents percentage of GFP-positive
cells that also express detectable myogenin by
immunostaining. Individual cells were evaluated
for expression of each marker. A minimum of
250 cells were counted from random fields. Error
bars indicate the mean ± SE of three independent
experiments.
(C) Representative FACS plots of myoblasts (GM)
and myocytes (DM3) infected with retroviral
pLE-myog3R-GFP construct. Gated population
indicates GFP-positive myocyte population
employed in subsequent experiments.
(D) Histogram representation of GFP expression in
three independent experimental FACS profiles on
myoblasts (GM) and myocytes (DM3) (*p < 0.001).
(E) Immunofluorescence images of GFP-positive
FACS-sorted myocytes cultured in conditioned
GM only (cGM) or in cGM with TAM and
p16/19si-RNA. Cells were labeled for Ki67 (red)
and GFP (green) as well as Hoechst 33258 (blue).
Scale bar represents 50 mm.
(F) Histogram represents percent of Ki67-positive
nuclei in GFP-positive FACS sorted population,
in cGM, treated with TAM and p16/19si, or treated
with Rbsi and p16/19si-RNA in tandem (DKD).
Growth medium (GM); a minimum of 100 nuclei
were counted from random fields for each trial.
Error bars indicate the mean ± SE of three
independent experiments (*p < 0.01, **p < 0.005).
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Charge´ and Rudnicki, 2004). Based on this pattern of transcrip-
tion, we developed a system to study cycling and dedifferentia-
tion in prospectively isolated populations derived from individual
differentiated muscle cells. We infected low-passage Rosa26-
CreERT2 Rblox/lox primary myoblasts with a retroviral vector in
which GFP expression is under the control of the myogenin
promoter (pLE-myog3R-GFP). To verify the fidelity of myogenin
and GFP coexpression, pLE-myog3R-GFP myoblasts were
sparsely seeded in growth medium or differentiation medium
for 72 hr and stained for myogenin and GFP. IF analysis clearly
showed that GFP and myogenin expression were upregulated
in the differentiating (DM3) myocyte population (Figure 4A).
Quantification of IF data indicated that only 0.9% of the cells
are GFP positive in growth conditions, probably representing
spontaneous differentiation. In differentiated cultures, GFP
expression correlated with myogenin immunoreactivity, and
27% ± 2.0% of the cells had detectable GFP levels (Figure 4Bi).
To verify the fidelity of myogenin expression in GFP-positive
cells, we scored elongated GFP-positive myocytes for myoge-204 Cell Stem Cell 7, 198–213, August 6, 2010 ª2010 Elsevier Inc.nin. Our data indicate that 98.4% ± 1.8% of cells were GFP+
myogenin+ (Figure 4Bii). High-throughput analysis of GFP
expression in myoblasts and myocytes was also performed by
fluorescence activated cell sorting (FACS), which showed that
35% of the cells expressed GFP after 3 days in differentiation
medium, whereas only 1.8% of cells in growth medium were
GFP+ (Figure 4D). Thus, pLE-myog3R-GFP infection of primary
myoblasts allows for reliable identification of myogenin-express-
ing cells.
Myoblasts seeded at low-density express myogenin and
undergo terminal differentiation in the absence of fusion (Shen
et al., 2003). We took advantage of this in vitro property of
muscle cells to investigate whether the dedifferentiation and
cell cycle reentry observed in differentiated multinucleated
myotubes could lead to proliferation after suppression of Rb
and p19ARF in differentiated mononucleated myocytes. In order
to follow the fate of single cells, the following experiments were
performed with individual pLE-myog3R-GFP myocytes. First,
sparsely seeded primary muscle cells, maintained in DM for
72 hr, were sorted on the basis of GFP expression as depicted
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differentiated muscle cells were capable of proliferation, the
FACS-sorted population was cultured in conditioned growth
medium (cGM) for up to 48 hr and then stained for GFP and
Ki67 (Figure 4E, top). Only 2.3% of GFP+ cells had Ki67-positive
nuclei. In contrast, GFP+ cells treated with TAM 24 hr prior to
FACS sorting and with p16/19si 12 hr after FACS sorting
(Figure 4E, bottom) exhibited Ki67 nuclear staining in 25% of
the GFP+ population 48 hr after culture in cGM (Figure 4F).
As an alternative method to suppress Rb and p16/19, siRNAs
against Rb and p16/19 were used to transiently reduce both
transcripts. Analyses to determine the ideal dosage and method
of siRNA application showed that most efficient double knock-
down (DKD) occurred after tandem treatment of primary muscle
cells with Rbsi, a 12 hr recovery period, followed by treatment
with p16/19si. DKD treatment of FACS-sorted GFP+ cells
resulted in 8.6% Ki67+ nuclei (Figure 4F). That the frequency of
DNA synthesis was lower in DKD-treated cells than in those
treated with TAM and p16/19si was expected given the lower
efficiency of knockdown compared to TAM treatment for Rb
suppression. The data from these two types of experiments
show that at the single cell level, differentiated myogenin-
expressing myocytes, like myotubes, efficiently enter S phase
only after suppression of both Rb and Ink4a gene expression.
We reasoned that if myocytes could divide, they would give
rise to clones. However, to rule out cell migration and definitively
show that a postmitotic myocyte divided, single-cell resolution
and clonal analysis was critical. Accordingly, to assess the
proliferative potential of myocytes, we first FACS-purified cells
twice in order to isolate individual differentiated GFP+ myocytes.
Individual myocytes were then sorted directly into microarrays of
hydrogel wells (Figure S4A; Lutolf et al., 2009), while a subset
was stained for coexpression of GFP andmyogenin (Figure S4B).
After treatment with Mocksi or DKD, proliferative myocytes were
scored as the percentage of microwells that had a minimum of 8
cells at 96 hr after treatment. 6.8% of DKD-treated myocytes
gave rise to clones in contrast to only 0.6% of Mocksi-treated
cells (Figure S4C). Taken together, these data support the
conclusion that myogenin-positive myocytes acquire prolifera-
tion potential after suppression of Rb and p16/19 expression.
Clonal Expansion and Proliferation of Individually
Purified Myocytes after Laser Microdissection
and Laser Pressure Catapulting
To determine definitively whether differentiated myocytes dedif-
ferentiate and proliferate, it is essential to monitor individual
myocytes before and after loss of pRb and ARF. For this purpose
we pioneered the use of photoactivated laser microdissection
(PALM) and laser pressure catapulting (LPC) with primary cells.
LPC is extensively used to obtain precise regions of fixed tissues
for DNA, RNA, and protein analyses. However, the use of LPC for
studies of living cells has been reported only in methodological
descriptions with robust cell lines in protocols by the developers
of PALM (Stich et al., 2003; Schutze et al., 2007). We optimized
LPC in order to ensure cell viability and isolate single cells from
mass cultures of primary myoblasts and myocytes. With the
PALM LPC system, cells are selected for isolation by the oper-
ator, who encircles the cell of interest with a unique software-
simulated shape; then the laser is directed to cut the membraneprecisely along the operator-drawn lines. The cut membrane is
subsequently catapulted by laser pressure and captured by
a robotic arm carrying an inverted media-containing cap. During
this procedure, the captured cell remains attached to the
membrane on which it grew, so that cell adhesion and mor-
phology are not disrupted. This technology allows a single cell
to be isolated intact on the surface on which it is growing. Via
LPC, the identification of a clone derived from a captured cell
is unambiguous because it is plated singly in a well. In this way
there is no question regarding the origin of the cells that
proliferate.
Laser microdissection and pressure catapulting analysis was
performed with myocytes. For this purpose primary myoblasts
expressing pLE-myog3R-GFP+ were sparsely seeded and
differentiated to become GFP+ myocytes and then treated with
either mock siRNA (Figure 5A) or for suppression of Rb and
ARF (Figures 5Bi and 5Ci). Individual myocytes were selected
based on their differentiated phenotype including elongated
morphology evident by phase microscopy (Figure 5Ai, left) and
bright GFP expression (Figures 5Bii and 5Cii, left). Laser micro-
dissection was used to mark and cut the membrane surrounding
prospectively identified single myocytes (green lines Figures 5Bii
and Figure 5Cii). Marking and recording membrane shapes
allowed for tracking of each membrane and the isolated cell on
its surface. The LPC burst locations that lead to catapulting are
indicated by the blue dots in the images in Figure 5Bii, which
also serve as a means of identifying the membrane. Typical
images obtained during the steps of the PALM and LPC isolation
process are shown in Figures 5Bii and 5Cii. Myocytemorphology
before and after membrane ablation did not significantly change.
Note in the example shown that 72 hr after capture, the mock-
treated myocyte is still associated with the membrane (Fig-
ure 5Aii, panel 4), and by 96 hr it has left the membrane but still
exists as a single adherent cell, although it was cultured in condi-
tioned growth medium since the time of capture (Figure 5Aii,
panel 5). Similarly, in individual myocytes treated for reduction
of Rb and ARF, morphology remained intact during the cutting
and catapulting (Figures 5Bii and 5Cii, left 3 panels). However,
in contrast to mock-treated myocytes, reduction of Rb (TAM or
siRNA) and ARF (siRNA) led to cell division and colony formation
in the immediate vicinity of the membrane (Figure 5Bii, fourth
panel from left, Figure 5Cii, fourth panel from left). Additional
examples of single GFP+ myocyte laser capture are shown in
Figures S4D and S4E.
In five independent PALM LPC isolation experiments, an anal-
ysis of a total of 250membranes verified that without reduction of
Rb and ARF, not a single captured myogenin-GFP+ myocyte
divided to produce a colony. In contrast, deletion of Rb and
suppression of ARF produced 34 colonies, a frequency of
13.8% (Figure 5D), and transient suppression of both Rb and
ARF (DKD) resulted in a colony frequency of 8.0%.
To increase the efficiency of identification of single GFP+
myocytes, and to thereby avoid desiccation, we increased
viability by first using FACS to enrich for myocytes expressing
myogenin-GFP, thus facilitating identification of single myocytes
(Figure S5A). Images of the captured control or TAM- and p16/
19si-treated myocytes are shown (Figures S5B and S5C). Again,
control-treated myocytes failed to produce colonies in condi-
tioned growth medium (Figure S5B), whereas myocytes in whichCell Stem Cell 7, 198–213, August 6, 2010 ª2010 Elsevier Inc. 205
Figure 5. Laser Microdissection and PALM LPC; Single Cell Isolation and Clonal Expansion of Dedifferentiated Myocytes
(A) (i) Schematic representations of the culture conditions, treatment with mock siRNA, and isolation by laser microdissection and catapulting of myogenin-GFP+
myocytes. Diagram also shows the fate of isolated cells 72 and 96 hr after isolation. (ii) Representative images of mock-treatedmyocyte (DM4) (panels left to right)
prior to microdissection, immediately after microdissection, after LPC isolation, 72 hr postisolation, and 96 hr postisolation. Scale bars represent 50 mm and
100 mm.
(B) (i) Schematic representations of the culture conditions, treatment with TAM and p16/19 siRNA, and isolation by laser microdissection and catapulting of
myogenin-GFP+ myocytes. Diagram also shows the fate of isolated cells 72 and 96 hr after isolation. (ii) Representative image of TAM- and p16/19siRNA-treated
myocyte (DM4): First panel, native GFP expression marks myogenin expression prior to microdissection; second panel, the same cell during microdissection;
third panel, after LPC isolation; fourth panel, 96 hr postisolation and visualization of expansion. Scale bars represent 50 mm and 100 mm.
(C) (i) Schematic representations of the culture conditions, treatment with Rb and p16/19 siRNA, and isolation by laser microdissection and catapulting of
myogenin-GFP+myocytes. Diagram also shows the fate of isolated cells 72 and 96 hr after isolation. (ii) Representative image of DKD-treatedmyocyte: first panel,
GFP expressionmarksmyogenin expression prior tomicrodissection; second panel, the same cell aftermicrodissection; third panel, after LPC; fourth panel, 72 hr
postisolation with visualization of expansion. Scale bars represent 50 mm and 200 mm.
(D) Histogram represents percentage of colony formation after PALM LPC cell isolation. Error bars indicate the mean ± SE of at least five independent
experiments, in which at least 50 membranes were captured for each myocyte trial, and at least 20 myoblast membranes were captured to verify cell survival
and capture efficiency.
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Figure 6. Dedifferentiated Myocytes Are
Capable of Expansion and Redifferentiation
into Mature Myotubes
(A) Phase contrast images of Rbsi and p16/19si
double-knockdown captured (DKDcap) myocyte
colonies and TAM with p16/19si-captured myo-
cyte (TAMcap) colonies at DM4, prior to protein
harvest for expression analysis. Scale bars
represent 150 mm.
(B) Western blot analysis of captured colonies in
GM and DM arranged from left to right according
to their differentiated morphologies in DM4;
protein levels of Rb (100 kDa), p19ARF (20 kDa),
myogenin (36 kDa), MHC (220 kDa), and Survivin
(20 kDa) as well as GAPDH (35 kDa) as a loading
control.
(C) Representative images of two DKDcap
myocyte colonies in DM4, labeled for GFP (green)
and myogenin (red) as well as Hoechst 33258
(blue). Scale bar represents 25 mm.
(D) Representative images of TAMcap myocyte
colony in DM4 labeled for MHC (red) and Hoechst
33258 (blue), a portion of which (bottom) was
infected with retrovirus reintroducing Rb expres-
sion. Scale bar represents 50 mm.
(E) Western blot analysis of Pax-7 protein (57 kDa)
levels in muscle cells in GM, DM at indicated time
points and with indicated treatments, and in the
DKDcap dedifferentiated clones.
(F) Western blot analysis of M-cadherin protein
(88 kDa) and MyoD (34 kDa) levels in primary
muscle cells under growth conditions (GM), differ-
entiated conditions (DM6) with indicated treat-
ments, and in the isolated dedifferentiated clones
(DKDcap1 and DKDcap2) in GM and DM4 (DM).
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survival (Figure S5C) exhibited a high frequency of 28.8% colony
formation (Figure 5E).
Redifferentiation of Captured Myocyte Colonies
after Exposure to Low Serum
Dedifferentiated muscle cells in axolotls have been shown to be
capable of proliferation and contribution to regenerating muscle,
although single cell tracking via genetic marking has not been
possible to date. After LPC capture, TAM- and p16/19si-treated
myocytes proliferated rapidly in GM, and most of the cells lost
myogenin expression after 72 hr, evidenced by lack of GFP (Fig-
ure S6B). To determine whether such dedifferentiated, actively
dividing mammalian myocytes were capable of redifferentiation,
we exposed these cells to differentiation conditions. However,
they continued to proliferate and never fused (Figure S6B, lower
panels), by comparison with control LPC-captured myoblasts,
which had started to fuse by 3 days in DM (Figure S6A). This
lack of differentiation is expected because the TAM-treated cells
had permanently lostRb expression. In contrast, Rb suppression(E) Histogram represents percentage of colony formation after PALM LPC cel
the scheme in Figure S5A. Error bars indicate the mean ± SE of at least four in
each myocyte trial. Primary muscle cells were differentiated for 4 days (DM4) atin DKD-captured myocytes was transient. Four colonies derived
from single DKD-treated captured myocytes were expanded,
exposed to DM for 4 days, and then assayed formusclemarkers,
either by microscopy or biochemically. The DKD colonies
spanned the spectrum of differentiation potential, as shown in
the top panels of Figures 6A and 6C. One colony (DKDcap1)
continued to proliferate despite being in DM whereas another
(DKDcap2) differentiated and fused. Heterogeneity in the
behavior of captured cells after transient knockdown may be
due to clonal variability after extensive proliferation.
Analysis of captured DKD colonies supports a function for pRb
in successful redifferentiation, because we found that DKDcap1
cells lost pRb expression, whereas the colonies that readily
fused and differentiated (DKDcap4 and DKDcap2) expressed
high levels of pRb in DM (Figure 6B). p19ARF expression in
DKDcap1 was high, the cells failed to upregulate GFP, and
endogenous Myogenin remained undetectable in DM (Fig-
ure 6C). In contrast, in the colonies that differentiated well, down-
regulation of p19ARF was observed in DM. Expression of GFP,
Myogenin, and MHC provided confirmation of differentiationl isolation after FACS isolation of GFP+ myocyte population as indicated by
dependent experiments, in which at least 50 membranes were captured for
the time of LPC isolation.
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Figure 7. Dedifferentiated Myocytes Are Capable of Fusing to
Muscle In Vivo
(A) Representative cross-sections of tibialis anterior 10 days postinjection of
2.53 105 cells from TAMcap1 and TAMcap1+Rb clonally expandedmyocytes
(see Figure 6). Incorporation of dedifferentiated myocytes into pre-existing
fibers can be visualized in merged fields by GFP+ staining (green) of
laminin-bound fibers (red), nuclei (blue); to enhance visualization, cells were in-
fected with a constitutive-eGFP expressing retroviral vector prior to injection
(n = 4, 3 of which had GFP+ fibers detected). Scale bar represents 50 mm.
(B) Schematic representation of the events after suppression of Rb and
p19ARF in primary differentiated myocytes and multinucleated myotubes.
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The relative changes in expression patterns of pRb, Ink4a, and
myogenic proteins by the DKDcap2 colony and by captured
myoblasts were similar (Figures S6C and S6D).
We reasoned that if pRb was reintroduced into the TAM- and
p16/19si-captured cells, redifferentiation and fusion should
occur. Therefore, we infected a subset of captured colonies
with a pMIG retrovirus vector expressing the human RB cDNA
(Sage et al., 2000).Wemonitored the TAMcapmyoblast colonies
after infection with pMIG-RB or control pMIG retrovirus and
determined that differentiation and fusion occurred in those
colonies that re-expressed pRB (Figure 6A, bottom). Analysis
of pRB protein levels showed the expected increase in pRB
protein that paralleled the upregulation of themyogenic proteins,
myogenin, and MHC (Figure 6B). In addition, Survivin levels
decreased in the TAMcap1 colony after pMIG-Rb infection
(Figure 6B, lane 6). However, ARF levels remained variable
among clones. The myogenic potential of TAMcap colonies
infected with pMIG-RB was also verified by immunofluores-
cence for MHC (Figure 6D). Together, these data demonstrate
that dedifferentiated myocytes are capable of successful redif-208 Cell Stem Cell 7, 198–213, August 6, 2010 ª2010 Elsevier Inc.ferentiation in vitro after capture and expansion and that this
process is dependent upon expression of Rb.
Muscle stem cells and proliferating primarymyoblasts express
themarker Pax7 (Charge´ andRudnicki, 2004).We testedwhether
musclecellswith reducedRband ink4adedifferentiated toapoint
such that expression of Pax7was reactivated. Primarymyoblasts
expressed Pax7 when they were proliferating under growth
conditions, but once in differentiation media for at least 72 hr,
Pax7 protein levels decreased and remained undetectable by
western analysis in mature myotubes (Figure 6E, lanes 2 and 3).
After reduction of pRb and ARF, dedifferentiating myotubes did
not re-express Pax7 (Figure 6E, lanes 4 and 5); however, myo-
cytes from the PALM-captured myogenin-positive population
re-expressedPax7once theyestablishedcolonies in conditioned
growth media (Figure 6E, lanes 6 and 7). We also tested expres-
sion of MyoD andM-cadherin, which have characteristic expres-
sionpatterns duringmuscle differentiation. Reduction of pRband
Arf caused a decrease of MyoD and M-cadherin protein levels in
myotubes (Figure 6F, left, and Figure S6E). In PALM-generated
clones, expression of MyoD and M-cadherin, like morphological
differentiation, was correlated with expression of Rb (Figure 6F,
right). Only clones that expressed pRb (DKDCap2) expressed
relatively high levels of MyoD and M-cadherin, both of which
increased somewhat during differentiation (Figure 6F, right, lanes
2 and 4). By contrast, the clone that did not express pRb
(DKDCap1), possibly resulting from mutation or deletion during
clonal selection, did not express detectable levels of M-cadherin
and expressed only low levels of MyoD in growth and differentia-
tion medium (Figure 6F, right, lanes 1 and 3).
Taken together, these results strongly support a role for Rb
and Ink4a in the maintenance of myogenic differentiation,
because their suppression in myogenin-expressing postmitotic
myocytes leads to division, expansion, and reactivation of
Pax7, as well as MyoD and m-cadherin expression patterns
consistent with myoblasts.
Captured and Expanded Myocytes Are Capable
of Contribution to Muscle In Vivo
Finally, we tested whether PALM LPC-isolated, expanded myo-
cytes could contribute to existing muscle in vivo. 1.5 3 105
DKD-derived dedifferentiated myocytes (DKDcap1 and
DKDcap2) were injected into the tibialis anterior (TA) of NOD/
SCID mice. Myogenin-GFP expression was used to track the
injected cells, because this marker was reliably detected in vitro
upondifferentiation (Figure6C). Tendaysafter injection,DKDcap1
cells, which exhibited no fusion in vitro, proliferated excessively
invivoandcausedseveredisruptionof themuscle lamininnetwork
at thesiteof injection (FigureS7, top).On theother hand,DKDcap2
cells readily fused to the existing muscle fibers and caused no
disruption of the laminin network (Figure S7, bottom).
We also analyzed in vivo contribution of colonies in which Rb
was deleted and ARF suppressed (TAMcap). Infection with
pMIG-RB restored RB expression and pLE-GFP retrovirus was
used to enhance visualization by expressing GFP constitutively
and at higher levels than those produced by the myogenin
reporter. Control TAMcap1 cells, which received control pMIG
and pLE-GFP infections, proliferated excessively in vivo (Fig-
ure 7A, top). By contrast, TAMcap1 cells with reintroduced RB
expression efficiently fused to existing muscle fibers, brightly
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without disruption of the existing laminin network (Figure 7A,
bottom). We conclude that if pRb expression is either transiently
suppressed or adequately restored, dedifferentiated myocytes
are capable of redifferentiation and incorporation by fusion to
existing muscle in vivo.
DISCUSSION
The molecular basis for the extraordinary disparity between
mammals and certain lower vertebrates, such as newts, axolotls,
and zebrafish, in their capacity to regenerate injured or ampu-
tated tissues remains a major unresolved biological question.
Mammalian regeneration of a muscle occurs only if that muscle
is replaced after mincing or grafting of small muscles, or when
chemical agents spare stem cells. Experiments of this type
indicate that significant architectural remodeling can occur in
lieu of scarring but that the extent of regeneration is limited by
the amount of replaced or surviving muscle (Carlson, 2003).
Although endogenous muscle stem cells can account for some
degree of regeneration (Collins and Partridge, 2005; Sacco
et al., 2008), they do not seem to suffice in extreme circum-
stances. Indeed, to date there is no evidence that the extensive
regeneration of entire muscles seen in urodeles can be achieved
by any known mammalian mechanism when a significant mass
of tissue is removed and not replaced. This regenerative poten-
tial is probably limited in part by a combination of excessive
demand for cell proliferation at the site of injury in order to
replace lost tissue, and an inhibition of architectural remodeling
by fibrosis. A possible basis for the failure of regeneration in
mammals, which has fascinated scientists for centuries, is a
capacity that regenerative vertebrates have retained and
mammals have lost: dedifferentiation.
Does dedifferentiation endow regenerative vertebrates with
capabilities that mammals lack? This question underscores the
need for novel insights into the molecular mechanisms of
dedifferentiation in order to discover what is missing in
mammals. In urodeles, compelling evidence from studies of
skeletal muscle suggests that dedifferentiation is a major mode
of tissue regeneration (Hay and Fischman, 1961; Lentz, 1969;
Kintner and Brockes, 1984; Lo et al., 1993; Tanaka et al., 1997;
Echeverri et al., 2001). Dedifferentiation involves two processes,
which are separable and independent: muscle cell fragmentation
into individual mononuclear cells and cell cycle re-entry followed
by proliferation (Velloso et al., 2000; Brockes and Kumar, 2008).
Inmammalianmyotubes producedwith the immortalized cell line
C2C12, overexpression of transcriptional factors present in the
blastema such as msx1 (Odelberg et al., 2000) or twist (Hjianto-
niou et al., 2008), or exposure to small molecules that disrupt
the cytoskeleton, have been reported to result in myotube
fragmentation (Perez et al., 2002). In the dedifferentiation studies
reported here, fragmentation of muscle cells was not observed,
which is in good agreement with reports showing that the frag-
mentation process in urodeles is independent of cell cycle
reentry (Velloso et al., 2000). In addition, because the trigger
and mechanism for muscle fragmentation and cellularization
in urodeles remains unknown, it is currently not possible to
determine whether a similar pathway exists in mammals. Under-
standing how fragmentation occurs and delineating the dediffer-entiation mechanisms are complementary but distinct goals in
muscle regeneration biology.
Molecular Regulation ofDedifferentiation byRb andARF
Our decision to suppress Rb in experiments directed at eluci-
dating the mechanisms underlying muscle dedifferentiation
was based on evidence in urodeles that pRb coordinates muscle
cell cycle entry in response to damage (Tanaka et al., 1997). In
mammals as in urodeles, cell cycle regulation by pRb is dynamic
and controlled primarily by its phosphorylation state (Lipinski
and Jacks, 1999; Burkhart and Sage, 2008). There is also a
wealth of data firmly establishing the tumor suppressor Rb as
a necessary player in the orchestration of mammalian muscle
cell differentiation, including evidence for a dual role in both
muscle cell cycle progression and exit (Gu et al., 1993; Zacksen-
haus et al., 1996; Puri et al., 2001; Blais et al., 2007). Indeed, Rb
null mice die before birth and lack differentiated muscles (Zack-
senhaus et al., 1996; Takahashi et al., 2003). Furthermore, pRb
has also been shown to act not only as a cell cycle regulator, but
also to impact differentiation and tissue-specific gene expression
directly by binding histone deacetylase 1 (HDAC1) and promot-
ing activation of muscle genes such as MyoD (Puri et al., 2001).
Once differentiation occurs, this state is stably maintained, at
least in mammals. This stability is underscored by the inability to
reverse differentiation simply by inactivating pRb in primary dif-
ferentiated mammalian muscle cells (Camarda et al., 2004; Huh
et al., 2004). Indeed, studies reporting otherwise have been
confounded by the use of immortalized cell lines such as C2C12
(Guetal., 1993;Blaisetal., 2007),whichweshowherehaveadele-
tion in the ink4a locus and therefore do not express the ink4a
products. Lossor suppressionofRb leadsonly tomoderate dedif-
ferentiation, as demonstrated by the reduced accumulation of
myogenin andMHC (Figure 3). In fact, as shown in this report and
by others previously (Camarda et al., 2004; Huh et al., 2004), it
is remarkable how little phenotypic change occurs in primary
differentiated skeletal muscle cells when Rb is suppressed.
The minimal impact of pRb absence alone on muscle dediffer-
entiation suggested that maintenance of mammalian differentia-
tion is ensured by a separate mechanism. Whereas the basal
Rb and p53 pathways are functional in lower vertebrates, we
reasoned that a modulator that is absent in regeneration-
competent vertebrates would be a good candidate regeneration
suppressor in mammals. We therefore focused on the ink4a
locus and ARF in particular. Unlike Rb, inactivation of ARF alone
in knockout mice has no apparent effect on differentiation
(Serrano et al., 1996; Kamijo et al., 1997). In agreement with
these reports, we found that suppressing ARF alone had no
effect on muscle differentiation or dedifferentiation. Loss of Rb
led to elevated expression and protein levels of ARF. Concomi-
tant inactivation of Rb and ARF caused extensive loss of differ-
entiation. Previously differentiated myotubes exhibited robust
DNA synthesis and expression of mitotic proteins upon acute
loss of Rb and p19ARF, suggesting that these two are nodal
points for intrinsic control of muscle cell cycle reentry. The
profound loss of architectural integrity and downregulation of
myogenin, MRF-4, MHC, and M-CK, further suggests that pRb
and ARF together are potent stabilizers of the differentiated
state. Notably, alternative approaches to induce cycling by
altering growth factor signaling and regeneration in mammalianCell Stem Cell 7, 198–213, August 6, 2010 ª2010 Elsevier Inc. 209
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moderate effect when compared to regenerating urodele
muscle. We speculate that ARF may inhibit robust cycling and
regeneration in this setting as well.
Our findings support the hypothesis that tumor suppression
mediated by the ink4a locus arose at the expense of regenera-
tion. Both p16ink4a and p19ARF have been recently shown to
contribute to the decline in regenerative potential of multiple
tissues during aging by affecting stem cell self-renewal (Sharp-
less and DePinho, 2007; Levi and Morrison, 2008). Our study
suggests that the ink4a locus has an additional negative impact
on tissue regeneration, i.e., suppression of cell cycle reentry
and dedifferentiation. The remarkable combined effect of acute
Rb and ARF loss strongly suggests (1) that continuous expres-
sion of pRb itself has an important function in maintaining the
differentiated state and (2) that the maintenance of the differen-
tiated state in mammals depends on complementary activities of
pRb and ARF. These findings are explicable in view of the known
need for continuous regulation of differentiation (Blau and
Baltimore, 1991; Yamanaka and Blau, 2010) as well as the
documented functions of Rb and ARF in preventing inappro-
priate cycling as tumor suppressors.
Single Cell Analyses of Reversal of Differentiation
Bulk culturesdonot allowadefinitive assessment that a given cell
has divided. The lack of transgenic animals, cellular complexity,
and rapid developmental changes observed in the blastema
has hindered analysis of dedifferentiation at the single cell level
in urodele regeneration until recently (Sobkow et al., 2006). In
mammalian muscle culture systems in which S phase reentry
was observed, the persistence of cells at earlier stages of differ-
entiation cannot be ruled out (Gu et al., 1993; Schneider et al.,
1994; Blais et al., 2007). In addition, continuous time-lapsemoni-
toring (Duckmanton et al., 2005) and single cell analysis are
essential, because reports of division of differentiated muscle
cells could be the result of cell migration. To overcome these
problems, we employed (1) dynamic single-cell tracking of
myocytes isolated in microwells by time-lapse microscopy and
(2) isolation of single myocytes by PALM laser capture micros-
copy. In particular, the laser microsdissection and catapulting
technology allows for unambiguous documentation of the
division of individual differentiated cells, as shown by the fact
that they are each selected and isolated on the basis of both their
morphology and their expression of a genetic marker of differen-
tiation, myogenin. These single cell studies clearly demonstrated
that cell cycle entry and expansion of individual differentiated
postmitotic myocytes occurs after Rb and p19ARF loss. By
contrast, untreated myocytes crawled off of membranes, but
never divided. We further demonstrated the regenerative
potential of dedifferentiated myocytes by inducing redifferentia-
tion. A subset of captured colonies produced by transient inacti-
vation ofRb andp19ARFwere exposed todifferentiationmedium
in culture and fused to form myotubes. Additionally, in myocytes
that had irreversibly lost Rb expression resulting from Cre-medi-
ated excision, reintroduction of RB by retroviral delivery not only
inducedmyotube formation andmuscle gene expression in vitro,
but also resulted in fusion and regeneration of myofibers in vivo
with typical architecture and no evidence of the tumorigenic
characteristics of cells that did not receive RB. These findings210 Cell Stem Cell 7, 198–213, August 6, 2010 ª2010 Elsevier Inc.suggest that transient inactivation of the two tumor suppressors
could yield dedifferentiated cells with extensive regenerative
potential as depicted in the diagram in Figure 7B.
We capitalized on evolutionary differences to genetically
modify the mammalian cell cycle regulatory pathways to more
closely mimic those found in lower vertebrates. Our results
reveal that it is possible to derive regenerative cells from differen-
tiated, postmitotic muscle in addition to classically defined
stem cells. Skeletal muscle cells can alternate between a differ-
entiated, postmitotic state and a proliferative, regenerative state,
retaining the essential characteristics of their cell type of origin
during the regenerative cycle. Our experiments implicate ARF
in the suppression of regeneration in mammalian cells by
impeding dedifferentiation. We postulate that a combination
of transient interventions to inactivate the Rb pathway while
suppressing ARF may be fruitfully employed to maximize a
mammalian regenerative response.
EXPERIMENTAL PROCEDURES
Mice and Primary Myoblast Preparation
Rosa26-CreERT2 Rblox/lox mice (Viatour et al., 2008) were crossed to mice
carrying a Cre-responsive b-galactosidase reporter allele (Ventura et al.,
2007). The hind leg muscles of 6- to 8-week-old offspring were prepared for
primary myoblast harvest as described (Rando and Blau, 1994). All animal
experiments were performed in accordance with Stanford University animal
use protocols.
Cell Culture
C2C12 and primary mouse myoblasts were cultured as described in Pajcini
et al. (2008) and Supplemental Experimental Procedures.
Cloning and Vector Construction
pLE-myog3R-GFP retroviral vector was constructed by subcloning the
myogenin promoter elements driving GFP expression from peGFPN1-hmyg
(a gift from Daniel Kemp-Novartis) into the pLE-GFP vector. See Supplemental
Experimental Procedures for details of the construct preparation and virus
production.
siRNA Silencing and Semiquantitative RT-PCR
RNA interference was carried out with small-interfering RNA duplexes
designed then screened for specific and effective knockdown of target genes.
Duplexes were designed for p16/19 sense sequence AGGUGAUGAUGAU
GGGCAAUU and p19ARF sense sequence GCUCUGGCUUUCGUGAACAUG
or ordered directly as ON-TARGETplus siRNA Rb1 (J-047474-06) from
Thermo/Dharmacon. For control transfections, nontargeting siRNA#1
(D-001810-01-05) and siGlo-Greenwere purchased fromThermo/Dharmacon.
Transfections of siRNA duplexes, resuspended in siRNA buffer (Dharmacon),
were carried out after differentiation of myocytes or after fusion of myotubes
at 48–72 hr in DM with siImporter transfection reagent (Millipore) as per manu-
facturer’s instructions. Transfectionmixwasadded to cells after supplemented
to differentiation media for 12 hr. RNA was harvested from C2C12 or primary
cells in GM or DM by RNeasy mini kit (QIAGEN) and 200 ng of total RNA was
used in semiquantitative RT-PCR analysis with Superscript III One-Step
RT-PCR (invitrogen). Primers designed for genes tested and details of the
PCR reactions may be found in Supplemental Experimental Procedures.
BrdU Analysis
5-bromo-20-deoxy-uridine (BrdU) labeling and detection kit (Roche) was used
according to the manufacturer’s instructions. BrdU labeling reagent was
added to the cells with fresh DM media for 12 hr.
Western Analysis
Cells were lysed at room temperature in lysis buffer (50 mM Tris [pH 7.5],
10 mM MgCl2, 0.3 M NaCl, 2% IGEPAL). When necessary, membranes were
Cell Stem Cell
Induction of Proliferation in Postmitotic Musclestripped by incubating at 50C for 45 min and then 1 hr at RT in stripping buffer
(100 mM 2-mercaptoethanol, 2% SDS, 62 mM Tris [pH 7]).
See Supplemental Experimental Procedures for details of antibody use.Immunofluorescence
C2C12 myotubes and primary myocytes or myotubes seeded densely
for fusion or sparsely for differentiation as described above were fixed and
permeabilized as per manufacturer’s instructions when costaining with BrdU
or with 1.5%paraformaldehyde 15min at room temperature (RT) then permea-
bilized with 0.3% Triton-PBS 10 min at RT. See Supplemental Experimental
Procedures for details of antibody use.
Cells were imaged with Zeiss Axioplan2 with 403 water immersion
objective, Zeiss Axiovert 200M, or Zeiss Observer Z1 with NeoFluar 103 or
LD Plan NeoFluar 203 objectives while ORCA-ER C4742-95; Hamamatsu
Photonics, or Axiocam MRm cameras were used to capture images. Openlab
5.0.2, Volocity 3.6.1 (Improvision), and PALM Robo V4 (Zeiss) were the
software used for image acquisition. Images were composed and edited in
Photoshop CS (Adobe). Background was reduced with contrast adjustments
and color balance was performed to enhance colors. All modifications were
applied to the entire image.FACS Sorting
Cells were harvested from culture dishes after 0.05% trypsin treatment,
centrifuged, resuspended in FACS buffer (PBS + 2% GS + 2 mM EDTA), and
kept on ice until analysis. Cells were analyzed and sorted with a FACSVantage
SE (BD Biosciences), with the DIVA analysis software. Dead cells were gated
out by staining with PI (1 mg/ml), and cells were sorted for GFP expression at
low pressure to preserve cell viability. Double sort was carried out in order
to obtain a purity of 99% viable cells. In the second sort, cells were sorted
directly in GM or DM as indicated and then seeded in different platforms
(microwells or PALM duplex dishes).PALM LPC
Primary myoblasts were sparsely seeded for differentiation in 50mm or 35mm
laminin (Roche) -coated Duplexdishes (Zeiss). See Supplemental Experi-
mental Procedures for details. Laser ablation was carried out after stage
calibration, laser focus, and optical focus calibration as per manufacturer’s
instructions, in a Zeiss Observer Z1 inverted microscope outfitted with
PALMMicrobeam (Zeiss). Ablatedmembranes were catapulted by LPC bursts
into Roboarm SingleTube Capture II receptacles (500 ml eppendorf tube cap)
with 80 ml of media. Membrane/myocyte capture was verified after capture
by direct observation of the captured receptacle. Total volume of the recep-
tacle was transferred into 12- or 24-well collagen-coated plates, where
captured myocytes were cultured in conditioned growth media (cGM), which
was harvested from actively dividing myoblasts and 0.2 mm filtered.Immunocytochemistry
10 days after injection, TA muscles were dissected and immersed in PBS/
0.5%EM-grade PFA (Polysciences) for 2 hr at RT followed by overnight immer-
sion in PBS with 20% sucrose at 4C. Section staining and image analysis was
performed as described in Pajcini et al. (2008).Time-Lapse Microscopy
Primary myotubes were imaged with Zeiss Axiovert 200M equipped with
time-lapse apparatus CTI-Controller 3700 Digital; Tempcontrol 37-2 digital;
scanning stage Incubator XL 100/135 (PECON). Frames were captured every
10min for a total of 50 hr, encompassing days 5 and 6 during primarymyotube
fusion and maturation. Images were acquired and analyzed with Volocity 3.6.1
(Improvision).SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and two movies and can be
found with this article online at doi:10.1016/j.stem.2010.05.022.ACKNOWLEDGMENTS
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